GC Biopharma(006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that a review paper comprehensively analyzing the safety and immunogenicity of its ...
A herpes zoster vaccine is safe in adults with autoimmune rheumatic disease and elicits a strong immune response, but responses are weaker in those on rituximab or mycophenolate, per a phase 4 study.
No vaccine is currently available for Lassa fever, a viral hemorrhagic disease that is estimated to cause thousands of deaths each year in western Africa. A replication-competent recombinant vesicular ...
SAN CARLOS, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced financial results for the fourth quarter and full year ...
Yale researchers have developed a machine learning model, called Immunostruct, that can help scientists create more ...
Morning Overview on MSN
Universal vaccine research advances, but a broad shot is still years away
The U.S. government and academic labs are pushing multiple universal vaccine candidates through early clinical trials, targeting influenza strains and coronaviruses that mutate faster than today’s ...
India's HPV vaccine, Cervavac, faces delays for inclusion in immunization programs due to ongoing studies and competition ...
Q4 2025 Management View Steven Lo, President and CEO, highlighted several recent milestones, including a partnership with Dynavax for the oral COVID-19 vaccine candidate and the publication of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results